EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker

Yuting Gou, Yongxiang Li iD, Yiyang Wang, Haotian Ma, Haocong Li, Reyima Geni, Dilimulati Ismtula, Chenming Guo iD

Breast Cancer: Targets and Therapy · 2025-12 · Volume 17 · 1439-1461

DOI: 10.2147/bctt.s553681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2025-12. Verfasst von Yuting Gou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Center of Digestive and Vascular, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republ…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BEND3methylationpan-cancerprognosistumor immunity

Autor:innen und Institutionen

  • Department of Breast Surgery, Center of Digestive and Vascular, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.
  • Department of Clinical Medicine, Xinjiang Medical University, Urumqi, People's Republic of China.
  • State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.

ORCID-Profile: Yongxiang Li, Chenming Guo

Zitieren

APA

Gou, Y., Li, Y., Wang, Y., Ma, H., Li, H., Geni, R., Ismtula, D., & Guo, C. (2025). Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker. Breast Cancer: Targets and Therapy, Volume 17, 1439-1461. https://doi.org/10.2147/bctt.s553681

Vancouver

Gou Y, Li Y, Wang Y, Ma H, Li H, Geni R, et al. Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker. Breast Cancer: Targets and Therapy. 2025;Volume 17:1439-1461. doi:10.2147/bctt.s553681

BibTeX
@article{Gou2025,
  author = {Gou, Yuting and Li, Yongxiang and Wang, Yiyang and Ma, Haotian and Li, Haocong and Geni, Reyima and Ismtula, Dilimulati and Guo, Chenming},
  title = {Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2025},
  volume = {Volume 17},
  pages = {1439--1461},
  doi = {10.2147/bctt.s553681}
}
Kostenlos starten →